H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
COVID-19 patients at high risk for developing complications associated with blood clots

COVID-19 patients at high risk for developing complications associated with blood clots

Chasing the elusive dream of a COVID cure

Chasing the elusive dream of a COVID cure

Viral shedding among pre-symptomatic COVID-19 patients finds study

Viral shedding among pre-symptomatic COVID-19 patients finds study

Visual Science designs a scientific model of  SARS-Cov-2 virus

Visual Science designs a scientific model of SARS-Cov-2 virus

Lessons for COVID-19 from 2009 H1N1

Lessons for COVID-19 from 2009 H1N1

Low albumin levels could predict poor outcome in COVID-19

Low albumin levels could predict poor outcome in COVID-19

Study shows 19 out of 25 COVID-19 patients improved with convalescent plasma treatment

Study shows 19 out of 25 COVID-19 patients improved with convalescent plasma treatment

Passive immummization can offer instant, short-term fortification against infectious agents

Passive immummization can offer instant, short-term fortification against infectious agents

COVID-19 may contribute to exponential growth of Parkinson's disease in future

COVID-19 may contribute to exponential growth of Parkinson's disease in future

Expanding sick leave protection is crucial during the COVID-19 crisis

Expanding sick leave protection is crucial during the COVID-19 crisis

Southwest CEO’s boast about airplanes’ low COVID risk flies by key concerns

Southwest CEO’s boast about airplanes’ low COVID risk flies by key concerns

10,000 liters of NaOClean Asia's disinfectant solution to be donated to nursing homes, churches

10,000 liters of NaOClean Asia's disinfectant solution to be donated to nursing homes, churches

Italy develops vaccine candidate that neutralizes SARS-CoV-2 in mice

Italy develops vaccine candidate that neutralizes SARS-CoV-2 in mice

Children are immune prepared for SARS-CoV-2

Children are immune prepared for SARS-CoV-2

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

Boston Children's Hospital launches two-pronged study of COVID-19 in children

Boston Children's Hospital launches two-pronged study of COVID-19 in children

Study looks into COVID‐19 preparedness in Michigan nursing homes

Study looks into COVID‐19 preparedness in Michigan nursing homes

Biden says OSHA isn’t doing enough to protect workers’ from COVID-19

Biden says OSHA isn’t doing enough to protect workers’ from COVID-19

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Scientists estimate fatality ratio across full spectrum of COVID-19 disease

Scientists estimate fatality ratio across full spectrum of COVID-19 disease